Previous Article |
Table of Contents
| Next Article
* Department of Neuropharmacology, The Scripps Research Institute,
10550 North Torrey Pines Road, La Jolla, CA 92037;
Communicated by Floyd E. Bloom, The Scripps Research Institute,
La Jolla, CA, December 24, 2002 (received for review October 23, 2002)
We examined the interaction of ethanol with the
alcohol|GABA IPSP/Cs|paired-pulse
facilitation|miniature synaptic
current|electrophysiology
The amygdala formation is a
complex of interconnected nuclei that has been implicated in various
physiological functions such as attention (1), memory (1-4), emotion
(5-7), and autonomic control (3). This complex has been linked to the
motivational effects of drugs of abuse and alcoholism in particular
(8).
The There has been a continuing controversy over the ability of ethanol to
enhance GABAergic neurotransmission [inhibitory postsynaptic potentials/inhibitory postsynaptic currents (IPSP/Cs)] in CNS neurons under basal conditions in other brain regions (see
Discussion and refs. 15-18). Therefore, we have
investigated effects of acute ethanol on basic membrane properties and
on inhibitory GABAergic transmission within the CeA in a slice preparation.
Here we report that, in contrast to other brain regions, acute
superfusion of low ethanol concentrations augments three measures of
GABAergic neurotransmission (spontaneous and evoked IPSP/Cs and
responses to exogenously applied GABA) in most CeA neurons in
brain slices taken from rats. These findings add further support for
the contention that GABA-ethanol interactions in central amygdala play
some role in the reinforcing effects of ethanol.
Slice Preparation.
We prepared amygdala slices from male Sprague-Dawley rats
(100-300 g) that were anesthetized with halothane (3%) and
decapitated, and the brains were rapidly removed into ice-cold
artificial cerebrospinal fluid (ACSF) gassed with 95%
O2/5% CO2. Transverse
slices 400 µm thick were cut on a Vibroslicer (Campden) or a
Leica VT 1000S (McBain Instruments, Chatsworth, CA), incubated in an
interface configuration for Intracellular Recording.
We recorded from CeA neurons with sharp micropipettes (containing 3 M
KCl) using discontinuous voltage- or current-clamp mode. In
voltage-clamp mode, we used a switching frequency of 3-5 kHz and
continuously monitored, on a separate oscilloscope, electrode settling
time and capacitance neutralization at the head stage. The data were
acquired with an Axoclamp-2A preamplifier (Axon Instruments, Foster
City, CA) and stored for later analysis by using
PCLAMP software (Axon Instruments). We evoked
pharmacologically isolated IPSP/Cs by stimulating locally within the
CeA through a bipolar stimulating electrode and superfusing the
glutamate receptor blockers 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM) and DL-2-amino-5-phosphonovalerate (APV, 30 µM)
to isolate GABAergic IPSP/Cs. In five cells, we also applied 1 µM
CGP 55845A [a GABA type B (GABAB) antagonist],
to further isolate GABA type A (GABAA)
receptor-mediated IPSP/Cs.
In most neurons, we held the cells near their resting membrane
potential (RMP) and applied hyperpolarizing and depolarizing voltage
commands or current steps (200-pA increments, 750-msec duration) to
generate current-voltage and/or voltage-current curves, respectively. The evoked IPSP/C amplitudes and current-voltage or voltage-current responses were quantified by
CLAMPFIT software (Axon Instruments). We also used a
paired-pulse facilitation (PPF) protocol with an interstimulus interval
of 50 msec and stimulus strength adjusted such that the amplitude of
the first IPSP/C of the pair was 50% of maximal amplitude of the
IPSP/C determined in the input/output (I/O) relationship.
We took measures before ethanol (control), during ethanol (5-15 min),
and after (20-30 min) ethanol washout and calculated the ratio between
the second and first IPSP/C (IPSP/C2 to IPSP/C1). We express all
values as mean ± SEM. We subjected data to a between-subject or
within-subject ANOVA with repeated measures, and the Newman-Keuls post
hoc test with P < 0.05 considered statistically
significant. When appropriate we used the Student's paired or unpaired
t test.
Whole-Cell Patch-Clamp Recording of Miniature IPSCs (mIPSCs).
In another set of neurons, we recorded from CeA using the
"blind" method of whole-cell patch-clamp in the presence of 10 µM CNQX, 30 µM APV, 1 µM CGP 55845A, and 1 µM tetrodotoxin
(TTX). All GABAA IPSC recordings were made with
electrodes filled with an internal solution containing 135 mM KCl, 10 mM Hepes, 2 mM MgCl2, 0.5 mM EGTA, 5 mM ATP, and
1 mM GTP (the latter two added fresh on the day of recording), with pH
values of 7.2-7.3 and osmolarity of 275-290. We pulled patch pipettes
on a Flaming/Brown puller from borosilicate glass (input resistance
2-3 M GABA Pressure Application.
We applied GABA (5 µM in the pipette) locally near the recorded
neuron by pressure (pipette tip diameter, 2-4 µm; pressure, 1-10
psi; duration, 0.5-3 sec). The GABA responses were recorded in
current-clamp mode and in the presence of glutamate receptor blockers
APV (30 µM) and CNQX (10 µM), together with 1 µM CGP 55845A and 1 µM TTX (to minimize presynaptic effects). The neurons were held near
their RMPs ( Drugs.
CGP 55845A was a gift from Novartis Pharma (Basel). We purchased
APV and CNQX from Tocris Cookson (Ellison, MO), bicuculline and GABA
from Sigma, TTX from Calbiochem, and ethanol from Remet (La Mirada,
CA). To avoid loss of ethanol by evaporation, we diluted solutions in
gassed ACSF from sealed stock solutions of reagent-grade 95% ethyl
alcohol in water immediately before administration.
CeA Neuronal Properties.
We recorded from a total of 99 CeA neurons; they had a mean RMP of
Ethanol: Evoked IPSP/Cs.
We examined the acute effects of 44 mM ethanol on basic membrane
properties of CeA neurons. Ethanol had no significant
(P > 0.1) effect on membrane potential,
voltage-current and current-voltage curves, input resistance, or
spike amplitudes (data not shown). However, in the presence of
glutamate receptor blockers CNQX and APV, 44 mM ethanol clearly
enhanced the isolated GABA-mediated IPSC amplitudes (Fig.
1A) in 7 of 10 neurons tested
(Table 1). Statistical analysis done on
all 10 neurons showed that ethanol significantly [F(1,
23) = 7.205, P < 0.05] increased mean evoked IPSC amplitudes over all stimulus strengths (to 161 ± 7% of control at maximal stimulus intensity), with recovery on washout for 12 min
(99 ± 4% of control at maximal strength; Fig.
1B). The ethanol-induced enhancement of IPSCs was measurable
at
Neuroscience
Ethanol increases GABAergic transmission at both pre- and
postsynaptic sites in rat central amygdala neurons
,
, and
Department of Psychiatry, Duke University, Durham, NC
27710; and
Department of Pharmacology and Physiology,
Drexel University College of Medicine, Philadelphia, PA 19102
![]()
Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-aminobutyric acid (GABA)ergic system in neurons of slices of the
rat central amygdala nucleus (CeA), a brain region thought to be
critical for the reinforcing effects of ethanol. Brief superfusion of
11-66 mM ethanol significantly increased GABA type A
(GABAA) receptor-mediated inhibitory postsynaptic
potentials (IPSPs) and currents (IPSCs) in most CeA neurons, with a low
apparent EC50 of 20 mM. Acute superfusion of 44 mM ethanol
increased the amplitude of evoked GABAA IPSPs and IPSCs in
70% of CeA neurons. The ethanol enhancement of IPSPs and IPSCs
occurred to a similar extent in the presence of the GABA type B
(GABAB) receptor antagonist CGP 55845A, suggesting that
this receptor is not involved in the ethanol effect on CeA neurons.
Ethanol superfusion also decreased paired-pulse facilitation of evoked
GABAA IPSPs and IPSCs and always increased the frequency and sometimes the amplitude of spontaneous miniature GABAA
IPSCs as well as responses to local GABA application, indicating both presynaptic and postsynaptic sites of action for ethanol. Thus, the CeA
is the first brain region to reveal, without conditional treatments
such as GABAB antagonists, consistent, low-dose ethanol enhancement of GABAergic transmission at both pre- and postsynaptic sites. These findings add further support to the contention that the
ethanol-GABA interaction in CeA plays an important role in the
reinforcing effects of ethanol.
![]()
Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-aminobutyric acid (GABA)ergic system, particularly in the
central amygdala nucleus (CeA), has been implicated in the expression
of emotionality, including behavioral states of fear and anxiety, as
well as states associated with consummatory responses (9). The CeA is
considered to be crucial in mediating the behavioral effects of acute
and chronic ethanol consumption (10, 11). Because stress reduction has
long been considered to contribute to ethanol-seeking behavior in
humans, researchers hypothesized that the CeA and its connections might
be sites for a GABA-like action of ethanol to mediate ethanol
reinforcement. Behavioral studies indicate that injection of GABAergic
antagonists directly into the CeA decreases motivated responding for
oral self-administration of ethanol in rats, whereas infusion of GABA
agonists and benzodiazepines decreased anxiety (11, 12). Thus, these
studies suggest that GABAergic systems in the CeA play a major role in
the acute reinforcing effects of ethanol (13) and in the anxiogenic
response to ethanol withdrawal (14).
![]()
Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
30 min, and then submerged completely
and superfused continuously (flow rate, 2-4 ml/min) with warm
(31°C) gassed ACSF. The ACSF was composed of 130 mM NaCl, 3.5 mM KCl,
1.25 mM NaH2PO4, 1.5 mM
MgSO4·7H2O, 2.0 mM
CaCl2, 24 mM NaHCO3, and 10 mM glucose. The inner chamber had a total volume of 0.8 ml; at the
superfusion rates used, 90% replacement of the chamber solution could
be obtained within 1 min. Drugs were added to the ACSF from stock
solutions at known concentrations.
). The data were acquired with an Axoclamp-2A preamplifier
(Axon Instruments) and analyzed by using MINI 5.1 software (Synaptosoft, Leona, NJ). We evaluated ethanol effects on
frequency and amplitude of mIPSCs within individual neurons using
cumulative probability analysis, with statistical significance
determined by using the Kolmogorov-Smirnov nonparametric two-sample
test (P < 0.05 is considered significant).

77 mV) where, with
Cl
-containing recording pipettes, GABA
responses were depolarizing. After stable responses were
achieved, we took current and voltage measurements at several time
points before, during, and after ethanol application. We defined
ethanol potentiation of GABA responses as a 10% increase in peak response.
![]()
Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
76 ± 2 mV and mean input resistance (with sharp pipettes) of
105 ± 5 M
. In current-clamp mode, these CeA neurons had
several distinctive characteristics. The spike firing during a
depolarizing voltage step was either accommodating or nonaccommodating
and was followed by either a large after-hyperpolarizing potential (AHP) (38%) or very small AHP (62%). We defined the AHP as large when
the amplitude was
5-6 mV (duration
500 msec) and small when
at
1 mV (duration
250 msec), measured at 200 msec after the
depolarizing step. Generally, neurons with accommodated spike firing
also had larger AHPs compared with the nonaccommodating neurons. These
characteristics are consistent with previous reports of diverse cell
types in the CeA (19-21). To date, we have not seen any correlation
between the cell type (based on AHP size) and the responsivity to
ethanol (described below).
4 min (including the inflow "dead time") after the onset of
ethanol superfusion and was maximal at 6-8 min; it recovered after
10-15 min of washout. We saw no signs of acute tolerance even with
long ethanol applications.

View larger version (16K):
[in a new window]
Fig. 1.
Acute superfusion of ethanol increases the amplitude of evoked GABA
IPSCs, revealed in the presence of glutamatergic blockers.
(A) Superfusion of 44 mM ethanol (EtOH) for 10 min
increased the IPSC amplitude, with recovery on washout (12 min).
(B) Mean percent increases of IPSC amplitudes elicited
by 44 mM ethanol, averaged from 10 CeA neurons. (C)
Dose-response relationship for ethanol enhancement of mean IPSP/C
amplitudes in CeA neurons, expressed as percent of control. Ethanol
superfused for 7-10 min. Number of neurons for each ethanol
concentration: 11 mM, n = 5; 22 mM,
n = 5; 44 mM, n = 8; and 66 mM,
n = 4. The logistic curve, plotted by
ORIGIN software (Microcal Software, Northampton, MA)
using y = (A1
A2)/[1 + (x/xo)p + A2], gives an
apparent EC50 of 20 mM ethanol for IPSP/C enhancement.
Parameters of the logistic curve were set at 155% (upper asymptote
fixed) and 100% (lower asymptote fixed). The rate was fixed at 3.0, with "center" unfixed. Error bars, SEM.
Table 1.
Differential ethanol sensitivity of
CeA neurons
A dose-response analysis also showed that ethanol (11-66 mM) significantly enhanced the GABAergic IPSPs across the neuronal population as a whole (both ethanol-sensitive and -insensitive; Fig. 1C). The highest ethanol concentration, 66 mM, actually enhanced GABA IPSPs to a lesser extent than did 44 mM ethanol, reminiscent of the inverted U-shaped dose-response curve obtained from nucleus accumbens neurons (22). This ethanol-IPSP interaction in CeA had an apparent EC50 of 20 mM (Fig. 1C), lower than reported for most other neuron types.
We reported previously that in rat hippocampal slices, ethanol enhanced isolated GABAA IPSCs only if GABAB receptors were blocked (16). However, as indicated above, in 70% of CeA neurons ethanol increased IPSCs even without blocking GABAB receptors. To determine whether the enhancement might be increased further if GABAB receptors were blocked, in five neurons we superfused the GABAB receptor antagonist CGP 55845A (1 µM) together with the glutamate receptor blockers. Under these conditions, ethanol still enhanced the mean IPSC amplitude to 148 ± 3% of control (measured at maximal stimulus intensity; Fig. 2). Thus, in contrast to hippocampus (16) and nucleus accumbens (15), in CeA GABAB receptors do not seem to regulate ethanol enhancement of isolated IPSC amplitudes.
|
Paired-Pulse Studies.
Ethanol could act at either pre- or postsynaptic sites to enhance IPSP size. To determine whether ethanol changes the probability of GABA release at CeA synapses, we carried out three types of experiments. In the first set of experiments we examined PPF (at an interpulse interval of 50 msec), a phenomenon whereby a secondary synaptic response is increased by a preceding primary stimulation of equal intensity (23-25). Changes in PPF are inversely related to transmitter release such that a reduction of PPF is associated with an increased probability of transmitter release (26, 27). We found that superfusion of either 44 or 66 mM ethanol significantly decreased PPF of GABAA IPSP/Cs (relative to the control; P < 0.05; Fig. 3B), suggesting an increased GABA release. In two cells we observed PPF to become paired-pulse inhibition (Fig. 3A). A slight decrease of PPF was observed also in neurons superfused with lower concentrations of ethanol (11 or 22 mM), but this did not reach statistical significance (P > 0.05; Fig. 3).
|
Spontaneous IPSCs.
In recordings with sharp pipettes, the majority of neurons from control rats exhibited spontaneous synaptic events completely blocked by superfusion of bicuculline. Interestingly, in approximately half of neurons recorded, 44 mM ethanol clearly increased the frequency of these spontaneous IPSP/Cs (data not shown), suggesting a possible presynaptic site of action. In a second set of experiments, to quantify spontaneous mIPSCs, we recorded from six CeA neurons using whole-cell patch-clamp in the presence of 1 µM TTX, 1 µM CGP 55845A, and glutamatergic blockers (30 µM APV and 10 µM CNQX). Generally, a change in the frequency of mIPSCs implicates an altered probability of transmitter release, and a change in the amplitude of mIPSCs reflects alterations in the sensitivity of postsynaptic GABAA receptors (28, 29). Superfusion of 44 mM ethanol for 6-10 min increased the mean frequency of mIPSCs to 223 ± 31% of control and significantly shifted the cumulative frequency distribution to shorter interevent intervals in all six neurons (means: control, 0.46 ± 0.14 Hz; 44 mM ethanol, 0.89 ± 0.25 Hz; P < 0.05; Fig. 4 A, B, and D; Table 1), supporting the PPF data indicating an increased presynaptic release of GABA. These mIPSCs were blocked totally by superfusion of bicuculline (Fig. 4A). Furthermore, ethanol induced spontaneous mIPSC activity in one of the neurons that was silent during the control period.
|
There was also a significant increase in the mIPSC amplitudes during
ethanol application, to 150 ± 12% of control (P < 0.05) in four of the six neurons, suggesting a postsynaptic as well as
a presynaptic ethanol effect in some of these neurons. However, averaged over all six neurons, the mean amplitude of mIPSCs in the
controls and during 44 mM ethanol superfusion was 35 ± 7 and 40 ± 3 pA, respectively, which was not statistically significant (Fig. 4E). To verify that the apparent changes in frequency
were not due to amplitude increases bringing detectable events out of
the baseline noise into the discrimination window, we examined mIPSCs
in the same cell recorded at different holding potentials. As the
membrane potential is shifted away from equilibrium, a change in the
amplitude of the events should be detected, whereas the frequency
should stay the same (29). In fact, the amplitudes of mIPSCs in one
neuron voltage-clamped at
50 and
65 mV were significantly different
(P < 0.05), whereas the ethanol-induced frequency
increase was not (P > 0.05), further suggesting that increased frequency was independent of changes in amplitude.
GABA Responses.
In a different set of CeA neurons, to verify postsynaptic actions of ethanol further, we evoked GABAA responses by local application of 5 µM GABA from a pipette in the presence of 1 µM TTX to minimize presynaptic effects. Under these conditions, exogenous GABA evoked reproducible depolarizing potentials (in current-clamp mode) in CeA neurons that were nearly totally blocked by 30 µM bicuculline (Fig. 5A), suggesting that these responses were mediated primarily by GABAA receptors. In 11 of 16 neurons tested, 44 mM ethanol significantly [F(1, 44) = 7.279, P < 0.01] increased the mean GABA-induced potentials to 158 ± 9% of control (Fig. 5B, 1). In most (69%) of these cells (Table 1), ethanol potentiation of GABA responses occurred within 5 min and recovered to control levels (97 ± 3% of control) on washout (5-15 min). In two of these neurons (not included in the graph of Fig. 5B), the potentiation was followed by a depression, suggesting the development of rapid tolerance to ethanol in these CeA neurons. In the remaining five cells, 44 mM ethanol slightly decreased GABA responses to 83 ± 4% (Fig. 5B, 2). Thus, acute superfusion of 44 mM ethanol increased the amplitude of both GABAA IPSP/Cs and responses to exogenous GABA in almost the same percentage of neurons (Table 1), indicating that ethanol acts at the postsynaptic as well as the presynaptic level in these CeA neurons.
|
| |
Discussion |
|---|
|
|
|---|
This study has revealed direct effects of ethanol on GABAergic mechanisms in the rat CeA nucleus. Based on their electrophysiological properties, we found evidence for diverse cell types within the CeA, consistent with results of previous studies (19-21). Although we have observed no correlation between the cell type and sensitivity to ethanol, the two cell types could play a different role in the physiology of this brain region. We hypothesize that the cells with small AHPs will support higher firing frequencies consistent with their role as classical inhibitory interneurons. Our current studies using an infrared video-microscopic setup will help to correlate the physiology and morphology of these cell types better. Stimulation within the CeA elicited synaptic responses mediated by both glutamate (data not shown) and GABA receptors. Acute superfusion of low ethanol concentrations dose-dependently augmented GABAergic neurotransmission, as assessed by several methods, in most CeA neurons, with recovery after washout. Ethanol had no effect on basic membrane properties regardless of cell type recorded, consistent with findings in other brain regions (16-18, 30-35).
Ethanol has been reported to allosterically modulate the GABAA receptor complex and potentiate the effects of GABA in some preparations (36, 37). Nonetheless, in many brain areas other than amygdala, acute ethanol effects on GABAA synaptic responses were either negligible (22, 30, 32) or contingent on additional manipulations such as blockade of GABAB receptors (15, 16, 22) or stimulation in discrete segments of the neuronal afferents (17). In fact, ethanol did not alter currents evoked by exogenous GABA in hippocampus even with GABAB receptor blockade, suggesting that the ethanol-IPSP interaction seen there was mediated presynaptically (15, 16). O. J. Ariwodola and J. L. Weiner have found in rat hippocampal pyramidal neurons that ethanol significantly potentiates presynaptic GABAB receptor-mediated inhibition of GABAA IPSCs, effectively decreasing the overall enhancement effect of ethanol on GABA receptor-mediated neurotransmission at these synapses (personal communications). Our present results show that GABAB receptor blockade was not required in the CeA for the enhancement of IPSP/Cs by ethanol, nor did it potentate this effect, which suggests that the ethanol-IPSP interaction was exerted at least in part postsynaptically and that presynaptic GABAB receptors may not be involved in ethanol effects or may not be present on the GABA terminals in CeA. Nor did we observe, with the stimulus parameters used, evidence of a GABAB receptor-mediated postsynaptic component.
Our study has shown that in
70% of the CeA neurons tested, acute
superfusion of 44 mM ethanol augments the amplitudes of both evoked and
spontaneous GABAA receptor-mediated IPSP/Cs and responses to exogenous GABA in the presence of TTX, indicating that
ethanol exerts a significant postsynaptic effect in this brain region.
A substantial literature has reported inconsistent ethanol effects on
postsynaptic responses to exogenous GABA application (15, 22, 38-44).
The reasons for these discrepancies are not clear. It should be noted
that the concentrations of ethanol applied in most of our experiments
were relatively moderate (44 mM or less).
In many CeA neurons, we observed spontaneous events that were blocked completely by CNQX and GABAA receptor blockers. Further, the spontaneous bicuculline-sensitive IPSP/Cs were observed frequently, consistent with previous demonstrations of high numbers of GABA-containing neurons in the CeA (45, 46). With sharp pipettes, ethanol increased the frequency of such spontaneous GABAA receptor-mediated events in most neurons, in parallel with the enhancement of evoked IPSP/Cs in our recordings. This ethanol effect was confirmed by whole-cell recordings and quantification of mIPSCs (in TTX) in all CeA neurons. In fact, we found that ethanol increased mIPSC frequencies sometimes without significantly altering their amplitude distribution. These findings demonstrate that ethanol-induced enhancement of GABAA IPSP/Cs appears to be in part through presynaptic increase of GABA release. An increase in probability of GABA release also would account for the reduction of PPF of IPSP/Cs seen during acute ethanol. Ethanol also increased the mIPSC amplitudes in 67% of the cells tested. These data are consistent with the ethanol-induced increase of responses to exogenous GABA and further support the hypothesis that ethanol also has a postsynaptic effect.
Ethanol interactions with GABA receptors in CeA have been correlated with ethanol reinforcement, and adaptive changes in the GABAergic system seem to be involved in ethanol dependence (11, 36, 47). Our findings agree with behavioral studies suggesting an interaction between ethanol and the GABAergic system in the CeA (11, 12): GABAA receptor antagonists infused into the amygdala reduced ethanol consumption (12), whereas infusion of GABAA agonists and benzodiazepines decreased anxiety (11). It is worth emphasizing that quite low concentrations of ethanol (apparent EC50 = 20 mM), thought to be sedative in vivo, enhanced GABA-mediated IPSP/Cs in CeA neurons. This high ethanol sensitivity lends support to the hypothesis that this brain region is involved in the well known anxiolytic effect of ethanol.
In conclusion, we have shown that ethanol, at low concentrations, markedly enhances multiple measures of GABAergic inhibition at both the pre- and postsynaptic level in the CeA. Such effects are consistent with an overall reduction in the activity and output of the central nucleus [see also recent in vivo studies (48)] and may account in part for the anxiolytic or "tension-reducing" effect of ethanol consumption (11-13, 49). Further study of ethanol effects on the network characteristics of the amygdala may elucidate the biological and molecular substrates of the reinforcing effects of ethanol consumption and how those effects change during the development of dependence.
| |
Acknowledgements |
|---|
We thank Dr. G. Koob for critical comments and Drs. W. Fröstl and A. Suter (Novartis Pharma) for the gift of CGP-55854A. This work was supported by National Institutes of Health Grants AA06420, AA10994, DA03665, and NS38633 and the Veterans Affairs Merit Review.
| |
Abbreviations |
|---|
GABA,
-aminobutyric acid;
CeA, central amygdala
nucleus;
IPSP, inhibitory postsynaptic potential;
IPSC, inhibitory
postsynaptic current;
ACSF, artificial cerebrospinal fluid;
CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione;
APV, DL-2-amino-5-phosphonovalerate;
GABAB, GABA
type B;
GABAA, GABA type A;
RMP, resting membrane
potential;
PPF, paired-pulse facilitation;
mIPSC, miniature
GABAA IPSC;
TTX, tetrodotoxin;
AHP, after-hyperpolarizing
potential.
| |
Footnotes |
|---|
§ To whom correspondence should be addressed at: CVN-12, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037. E-mail: geobob{at}scripps.edu.
| |
References |
|---|
|
|
|---|
| 1. | McDonald, A. J. (1998) Prog. Neurobiol. 55, 257-332[CrossRef][ISI][Medline] . |
| 2. | Henke, P. G. (1985) Behav. Brain Res. 16, 19-24[CrossRef][ISI][Medline] . |
| 3. | Liubashina, O. , Jolkkonen, E. & Pitkanen, A. (2000) Neurosci. Lett. 291, 85-88[CrossRef][ISI][Medline] . |
| 4. | Holland, P. C. & Gallagher, M. (1999) Trends Cogn. Sci. 3, 65-73[CrossRef][ISI][Medline] . |
| 5. | Gentile, C. G. , Jarrell, T. W. , Teich, A. , McCabe, P. M. & Schneiderman, N. (1986) Behav. Brain Res. 20, 263-273[CrossRef][ISI][Medline] . |
| 6. | LeDoux, J. E. (1995) Annu. Rev. Psychol. 46, 209-235[CrossRef][ISI][Medline] . |
| 7. | Goosens, K. A. , Holt, W. & Maren, S. (2000) Behav. Brain Res. 114, 145-152[CrossRef][ISI][Medline] . |
| 8. | Koob, G. F. , Roberts, A. J. , Schulteis, G. , Parsons, L. H. , Heyser, C. J. , Hyytia, P. , Merlo-Pich, E. & Weiss, F. (1998) Alcohol. Clin. Exp. Res. 22, 3-9[CrossRef][ISI][Medline] . |
| 9. | Davis, M. , Rainnie, D. & Cassell, M. (1994) Trends Neurosci. 17, 208-214[CrossRef][ISI][Medline] . |
| 10. | Rassnick, S. , Heinrichs, S. C. , Britton, K. T. & Koob, G. F. (1993) Brain Res. 605, 25-32[CrossRef][ISI][Medline] . |
| 11. | Hyytia, P. & Koob, G. F. (1995) Eur. J. Pharmacol. 283, 151-159[CrossRef][ISI][Medline] . |
| 12. | Roberts, A. J. , Cole, M. & Koob, G. F. (1996) Alcohol. Clin. Exp. Res. 20, 1289-1298[CrossRef][ISI][Medline] . |
| 13. | Koob, G. F. , Rassnick, S. , Heinrichs, S. & Weiss, F. (1994) EXS 71, 103-114[Medline] . |
| 14. | Pich, E. M. , Lorang, M. , Yeganeh, M. , Rodriguez de Fonseca, F. , Raber, J. , Koob, G. F. & Weiss, F. (1995) J. Neurosci. 15, 5439-5447[Abstract]. |
| 15. | Siggins, G. , Nie, Z. & Madamba, S. (1999) in The "Drunken" Synapse: Studies of Alcohol Related Disorders, eds. Liu, Y. & Hunt, W. (Kluwer/Plenum, New York), pp. 135-143. |
| 16. |
Wan, F. J.
, Berton, F.
, Madamba, S. G.
, Francesconi, W.
& Siggins, G. R.
(1996)
Proc. Natl. Acad. Sci. USA
93,
5049-5054 |
| 17. |
Weiner, J. L.
, Gu, C.
& Dunwiddie, T. V.
(1997)
J. Neurophysiol.
77,
1306-1312 |
| 18. | Soldo, B. L. , Proctor, W. R. & Dunwiddie, T. V. (1994) Synapse 18, 94-103[CrossRef][ISI][Medline] . |
| 19. | Schiess, M. C. , Callahan, P. M. & Zheng, H. (1999) J. Neurosci. Res. 58, 663-673[CrossRef][ISI][Medline] . |
| 20. |
Rainnie, D. G.
, Fernhout, B. J.
& Shinnick-Gallagher, P.
(1992)
J. Pharmacol. Exp. Ther.
263,
846-858 |
| 21. |
Martina, M.
, Royer, S.
& Pare, D.
(1999)
J. Neurophysiol.
82,
1843-1854 |
| 22. |
Nie, Z.
, Madamba, S. G.
& Siggins, G. R.
(2000)
J. Pharmacol. Exp. Ther.
293,
654-661 |
| 23. | Zucker, R. S. (1989) Annu. Rev. Neurosci. 12, 13-31[CrossRef][ISI][Medline] . |
| 24. | Debanne, D. , Guerineau, N. C. , Gahwiler, B. H. & Thompson, S. M. (1996) J. Physiol. (London) 491, 163-176[ISI][Medline] . |
| 25. |
Jiang, L.
, Sun, S.
, Nedergaard, M.
& Kang, J.
(2000)
J. Physiol. (London)
523,
425-439 |
| 26. |
Andreasen, M.
& Hablitz, J. J.
(1994)
J. Neurophysiol.
72,
326-336 |
| 27. | Mennerick, S. & Zorumski, C. F. (1995) J. Physiol. (London) 488, 85-101[ISI][Medline] . |
| 28. |
De Koninck, Y.
& Mody, I.
(1994)
J. Neurophysiol.
71,
1318-1335 |
| 29. |
Otis, T. S.
, De Koninck, Y.
& Mody, I.
(1994)
Proc. Natl. Acad. Sci. USA
91,
7698-7702 |
| 30. | Siggins, G. R. , Pittman, Q. J. & French, E. D. (1987) Brain Res. 414, 22-34[CrossRef][ISI][Medline] . |
| 31. | Siggins, G. R. , Bloom, F. E. , French, E. D. , Madamba, S. G. , Mancillas, J. , Pittman, Q. J. & Rogers, J. (1987) Ann. N.Y. Acad. Sci. 492, 350-366[Abstract]. |
| 32. | Proctor, W. R. , Allan, A. M. & Dunwiddie, T. V. (1992) Alcohol. Clin. Exp. Res. 16, 480-489[CrossRef][ISI][Medline] . |
| 33. | Proctor, W. R. , Soldo, B. L. , Allan, A. M. & Dunwiddie, T. V. (1992) Brain Res. 595, 220-227[CrossRef][ISI][Medline] . |
| 34. |
Nie, Z.
, Madamba, S. G.
& Siggins, G. R.
(1994)
J. Pharmacol. Exp. Ther.
271,
1566-1573 |
| 35. |
Nie, Z.
, Yuan, X.
, Madamba, S. G.
& Siggins, G. R.
(1993)
J. Pharmacol. Exp. Ther.
266,
1705-1712 |
| 36. | Deitrich, R. A. , Dunwiddie, T. V. , Harris, R. A. & Erwin, V. G. (1989) Pharmacol. Rev. 41, 489-537[ISI][Medline] . |
| 37. | Harris, R. A. & Allan, A. M. (1989) Brain Res. 490, 26-32[CrossRef][ISI][Medline] . |
| 38. | Mihic, S. J. (1999) Neurochem. Int. 35, 115-123[CrossRef][ISI][Medline] . |
| 39. | Marszalec, W. , Aistrup, G. L. & Narahashi, T. (1998) Alcohol. Clin. Exp. Res. 22, 1516-1524[CrossRef][ISI][Medline] . |
| 40. | Aguayo, L. G. (1990) Eur. J. Pharmacol. 187, 127-130[CrossRef][ISI][Medline] . |
| 41. | Reynolds, J. N. & Prasad, A. (1991) Brain Res. 564, 138-142[CrossRef][ISI][Medline] . |
| 42. | Reynolds, J. N. , Prasad, A. & MacDonald, J. F. (1992) Eur. J. Pharmacol. 224, 173-181[CrossRef][ISI][Medline] . |
| 43. | Soldo, B. L. , Proctor, W. R. & Dunwiddie, T. V. (1998) Brain Res. 800, 187-197[CrossRef][ISI][Medline] . |
| 44. |
Signore, A. P.
& Yeh, H. H.
(2000)
J. Neurophysiol.
84,
247-254 |
| 45. | Nitecka, L. & Ben-Ari, Y. (1987) J. Comp. Neurol. 266, 45-55[CrossRef][ISI][Medline] . |
| 46. | Ben-Ari, Y. , Zigmond, R. E. , Shute, C. C. & Lewis, P. R. (1977) Brain Res. 120, 435-444[CrossRef][ISI][Medline] . |
| 47. | Tabakoff, B. & Hoffman, P. L. (1996) Neuron 16, 909-912[CrossRef][ISI][Medline] . |
| 48. | Naylor, J. C. , Simson, P. E. , Gibson, B. , Schneider, A. M. , Wilkins, E. , Firestone, A. & Choy, M. (2001) Alcohol. Clin. Exp. Res. 25, 1683-1688[Medline] . |
| 49. | Moller, C. , Wiklund, L. , Sommer, W. , Thorsell, A. & Heilig, M. (1997) Brain Res. 760, 94-101[CrossRef][ISI][Medline] . |
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
V. C. Cuzon, P. W. L. Yeh, Y. Yanagawa, K. Obata, and H. H. Yeh Ethanol Consumption during Early Pregnancy Alters the Disposition of Tangentially Migrating GABAergic Interneurons in the Fetal Cortex J. Neurosci., February 20, 2008; 28(8): 1854 - 1864. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Silberman, L. Shi, J. K. Brunso-Bechtold, and J. L. Weiner Distinct Mechanisms of Ethanol Potentiation of Local and Paracapsular GABAergic Synapses in the Rat Basolateral Amygdala J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 251 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Knapska, K. Radwanska, T. Werka, and L. Kaczmarek Functional Internal Complexity of Amygdala: Focus on Gene Activity Mapping After Behavioral Training and Drugs of Abuse Physiol Rev, October 1, 2007; 87(4): 1113 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Kelm, H. E. Criswell, and G. R. Breese Calcium Release from Presynaptic Internal Stores Is Required for Ethanol to Increase Spontaneous {gamma}-Aminobutyric Acid Release onto Cerebellum Purkinje Neurons J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 356 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Kang-Park, B. L. Kieffer, A. J. Roberts, G. R. Siggins, and S. D. Moore Presynaptic {delta} Opioid Receptors Regulate Ethanol Actions in Central Amygdala J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 917 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhu, B. Bie, and Z. Z. Pan Involvement of Non-NMDA Glutamate Receptors in Central Amygdala in Synaptic Actions of Ethanol and Ethanol-Induced Reward Behavior J. Neurosci., January 10, 2007; 27(2): 289 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Krystal, J. Staley, G. Mason, I. L. Petrakis, J. Kaufman, R. A. Harris, J. Gelernter, and J. Lappalainen {gamma}-Aminobutyric Acid Type A Receptors and Alcoholism: Intoxication, Dependence, Vulnerability, and Treatment. Arch Gen Psychiatry, September 1, 2006; 63(9): 957 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Proctor, L. Diao, R. K. Freund, M. D. Browning, and P. H. Wu Synaptic GABAergic and glutamatergic mechanisms underlying alcohol sensitivity in mouse hippocampal neurons J. Physiol., August 15, 2006; 575(1): 145 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. DuBois, A. Perlegas, D. W. Floyd, J. L. Weiner, and B. A. McCool Distinct Functional Characteristics of the Lateral/Basolateral Amygdala GABAergic System in C57BL/6J and DBA/2J Mice J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 629 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Zhu and D. M. Lovinger Ethanol Potentiates GABAergic Synaptic Transmission in a Postsynaptic Neuron/Synaptic Bouton Preparation From Basolateral Amygdala J Neurophysiol, July 1, 2006; 96(1): 433 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Roberto and G. R. Siggins Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala PNAS, June 20, 2006; 103(25): 9715 - 9720. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Carta, M. Mameli, and C. F. Valenzuela Alcohol Potently Modulates Climbing Fiber->Purkinje Neuron Synapses: Role of Metabotropic Glutamate Receptors J. Neurosci., February 15, 2006; 26(7): 1906 - 1912. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Wu, W. Poelchen, and W. R. Proctor Differential GABAB Receptor Modulation of Ethanol Effects on GABAA Synaptic Activity in Hippocampal CA1 Neurons J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1082 - 1089. [Abstract] [Full Text] [PDF] |
||||